Inventor · disambiguated record
Marc Gaston Venet
Also filed as: VENET MARC G · VENET MARC GASTON
54 granted patents·6 pending applications·1,148 citations·filing 1986–2007
99Inventor score
Files withJANSSEN PHARMACEUTICA NV46JANSSEN CILAG S A2VENET MARC GASTON2ANGIBAUD PATRICK R1ANGIBAUD PATRICK RENE1
Top patents by PatentIndex Score
60 records- 0198US6420387B1Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivativesJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Jul 16, 2002·97 cites·2 claims
- 0297US6187786B1Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazolesJANSSEN PHARMACEUTICA NV·Filed 1998·Granted Feb 13, 2001·119 cites·11 claims
- 0397US6037350AFarnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivativesJANSSEN PHARMACEUTICA NV·Filed 1996·Granted Mar 14, 2000·112 cites·27 claims
- 0495US6169096B1Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivativesJANSSEN PHARMACAEUTIC N V·Filed 1999·Granted Jan 2, 2001·133 cites·14 claims
- 0595US5968952AFarnesyl transferase inhibiting 2-quinolone derivativesJANSSEN PHARMACEUTICA NV·Filed 1996·Granted Oct 19, 1999·95 cites·13 claims
- 0695US5037829A(1H-azol-1-ylmethyl) substituted quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Aug 6, 1991·57 cites·20 claims
- 0795US5028606A(1H-azol-1-ylmethyl)substituted quinoxaline derivativesJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Jul 2, 1991·44 cites·13 claims
- 0891US6486187B1N-[4-(heteroarylmethyl)phenyl]-heteroarylaminesJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Nov 26, 2002·31 cites·10 claims
- 0989US7053105B2Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2001·Granted May 30, 2006·24 cites·19 claims
- 1086US5151421A(1h-azol-1-ylmethyl) substituted quinoxaline derivativesJANSSEN PHARMACEUTICA NV·Filed 1991·Granted Sep 29, 1992·29 cites·6 claims
- 1185US8329714B2Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomerVENET MARC GASTON·Filed 2007·Granted Dec 11, 2012·7 cites·9 claims
- 1285US8318753B2Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomerVENET MARC GASTON·Filed 2007·Granted Nov 27, 2012·7 cites·3 claims
- 1385US7943635B2Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 17, 2011·7 cites·9 claims
- 1484US7173040B2Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Feb 6, 2007·21 cites·8 claims
- 1584US7115630B2Metabotropic glutamate receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Oct 3, 2006·21 cites·10 claims
- 1684US6914066B21,2-annelated quinoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Jul 5, 2005·21 cites·8 claims
- 1784US6458800B11,2-annelated quinoline derivativesJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Oct 1, 2002·57 cites·9 claims
- 1884US4943574A(1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing themJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Jul 24, 1990·23 cites·11 claims
- 1983US6833375B2N-[4-(heteroarylmethyl)phenyl]-heteroarylaminesJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Dec 21, 2004·13 cites·7 claims
- 2082US7179825B2Retinoic acid mimetic anilidesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 20, 2007·4 cites·10 claims
- 2181US7241777B2Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 10, 2007·14 cites·8 claims
- 2281US7196094B2Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Mar 27, 2007·11 cites·9 claims
- 2380US6358961B1Farnesyltransferase inhibiting quinazolinonesJANNSEN CILAG S A·Filed 2000·Granted Mar 19, 2002·17 cites·1 claims
- 2479US7498343B2Mycobacterial inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Mar 3, 2009·19 cites·24 claims
- 2578US6177432B1Farnesyltransferase inhibiting quinazolinonesJANSSEN CILAG S A·Filed 1998·Granted Jan 23, 2001·40 cites·12 claims
- 2676US6319939B1Retinoic acid mimetic anlidesJANSSEN PHARMACEUTICA NV·Filed 1998·Granted Nov 20, 2001·29 cites·13 claims
- 2775US7071192B1Respiratory syncytial virus replication inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Jul 4, 2006·7 cites·16 claims
- 2875US6936626B2Retinoic acid mimetic anilidesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Aug 30, 2005·6 cites·11 claims
- 2974US7579352B2Retinoic acid mimetic anilidesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 25, 2009·1 cites·11 claims
- 3073US7129356B2Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Oct 31, 2006·6 cites·15 claims
- 3173US7067531B2Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivativesANGIBAUD PATRICK RENE·Filed 2001·Granted Jun 27, 2006·6 cites·12 claims
- 3273US6124330AN-[4-(Heteroarylmethyl)phenyl]-heteroarylaminesJANSSEN CILAG S A·Filed 1997·Granted Sep 26, 2000·25 cites·12 claims
- 3373US5612354A(1H-azol-1-ylmethyl)substituted quinoline derivativesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Mar 18, 1997·13 cites·9 claims
- 3469US7407969B2Respiratory syncytial virus replication inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Aug 5, 2008·1 cites·12 claims
- 3568US7205312B2N-[4-(heteroarylmethyl)phenyl]-heteroarylaminesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Apr 17, 2007·2 cites·11 claims
- 3666US7408063B21,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Aug 5, 2008·2 cites·5 claims
- 3765US7153958B2Farnesyl transferase inhibiting benzoheterocyclic derivativesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Dec 26, 2006·2 cites·36 claims
- 3864US6444812B1Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazolesJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Sep 3, 2002·2 cites·2 claims
- 3962US7378433B2N-[4-(heteroarylmethyl)phenyl]-heteroarylaminesJANSSEN PHARMACEUTICA NV·Filed 2006·Granted May 27, 2008·0 cites·24 claims
- 4059US2007105858A1Retinoic acid mimetic anilidesMABIRE DOMINIQUE·Filed 2006·Application pending·0 cites
- 4157US5185346A(1H-azol-1-ylmethyl)substituted quinoline derivativesHANSSEN PHARMACEUTICA·Filed 1991·Granted Feb 9, 1993·7 cites·18 claims
- 4253US2004167333A1Novel IL-5 inhibiting 6-azauracil derivatives for marking and identifying receptors and imaging organsFiled 2004·Application pending·0 cites
- 4352US2005090495A1Novel IL-5 inhibiting 6-azauracil derivatives for marking and identifying receptors and imaging organsFiled 2003·Application pending·0 cites
- 4452US2006135769A1Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivativesANGIBAUD PATRICK R·Filed 2006·Application pending·0 cites
- 4551US7655654B2Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazolesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Feb 2, 2010·0 cites·6 claims
- 4651US5663354AProcess for preparing enantiomerically pure 6-[(4-chlorophenyl) (1H-1,2,4-triazol-1-yl) methyl]-1-methyl-1H-benzotrizoleJANSSEN PHARMACEUTICA NV·Filed 1993·Granted Sep 2, 1997·4 cites·4 claims
- 4750US5746840AProcess for preparing enantiomerically pure 6-{4-chlorophenyl) (1 H-1,2,4-triazol-1-YL) methyl}-1-methyl-1 H-benzotriazoleJANSSEN PHARMACEUTICA NV·Filed 1997·Granted May 5, 1998·4 cites·1 claims
- 4849US6867207B2IL-5 inhibiting 6-azauracil derivativesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Mar 15, 2005·0 cites·7 claims
- 4949US2003114471A1Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomerFiled 2001·Application pending·0 cites
- 5048US2004067968A1Farnesyl transferase inhibiting 4-heterocyclyl quinoline and quinazolineFiled 2001·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →